VIP236

· Vincerx Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VIP236, covering 2024-11-15 to 2024-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer [Phase 1]